APA (7th ed.) Citation

CA, M., A, G., J, P., Y, M., WJ, S., K, S., . . . R, C. (2024). Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer. Cancer cell, 42(9), 1614. https://doi.org/10.1016/j.ccell.2024.08.002

Chicago Style (17th ed.) Citation

CA, McIntyre, et al. "Distinct Clinical Outcomes and Biological Features of Specific KRAS Mutants in Human Pancreatic Cancer." Cancer Cell 42, no. 9 (2024): 1614. https://doi.org/10.1016/j.ccell.2024.08.002.

MLA (9th ed.) Citation

CA, McIntyre, et al. "Distinct Clinical Outcomes and Biological Features of Specific KRAS Mutants in Human Pancreatic Cancer." Cancer Cell, vol. 42, no. 9, 2024, p. 1614, https://doi.org/10.1016/j.ccell.2024.08.002.